News

Pharma Commerce makes a return trip to Philly for insights on the latest approaches in patient assistance and adherence.

Cohort study examines the potential for spending to significantly decrease for individuals who use these generic versions of biologics.

The two company’s will provide consumers with a platform where they can compare drug prices.

The latest news for pharma industry insiders.

In this Pharmaceutical Commerce video interview, Joerg Tritschler, a partner in Simon-Kucher’s life sciences division, explores the two major strategies big pharma companies are employing amid current macro challenges and efforts to offset looming patent losses to blockbuster brands.

The latest news for pharma industry insiders.

Patients should not have to wait to access the medication they need.

Cross-sectional study explores the impact of this monumental Supreme Court ruling.

The latest news for pharma industry insiders.

Fighting for patient affordability doesn’t necessarily require a scapegoat.

Exploring how current and future legislation may impact the role of pharmacy benefit managers (PBMs).

A breakdown of the issues surrounding retail pharmacy—and what can be done to address these difficulties in a timely manner.

In this Pharmaceutical Commerce video interview, Joerg Tritschler, a partner in Simon-Kucher’s life sciences division, discusses the hottest therapeutic settings for dealmaking activity at the moment—and one platform approach in particular poised to be at the center of future M&A and licensing pursuits.

The latest news for pharma industry insiders.

Five of the company’s vaccines are currently in Phase III.

The latest news for pharma industry insiders.

A study investigates how a New Mexico law can impact patients’ out-of-pocket costs surrounding mental health and substance use disorder medications.

The latest news for pharma industry insiders.

The new option will help patients receive life-saving medications at an even quicker rate.

A study of patients with the long-term conditions who are required to switch to high-deductible health plans could potentially be more likely to experience diabetes complications than those who stay in standard insurance plans.

The latest news for pharma industry insiders.

In an interview with Pharma Commerce Associate Editor Don Tracy, Adrianna Nava, PhD, MPA, MSN, RN, President, National Association of Hispanic Nurses (NAHN) talks about the organization's mission and goals.

The organizations conducted an in-depth study of the program over the course of two years, publishing a white paper on the findings.

The latest news for pharma industry insiders.

The purpose for the deal, the CDMO says, is to meet the demand for commercial mammalian contract manufacturing.

In an interview with Pharma Commerce Associate Editor Don Tracy, Amy Niles, Chief Mission Officer, The PAN Foundation discusses the overall mission of the organization.

The latest news for pharma industry insiders.

A multiple myeloma survivor shares his story, including how patient assistance made a positive impact.